ID: ALA4789328

Max Phase: Preclinical

Molecular Formula: C21H25N3O

Molecular Weight: 335.45

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ccccc1N1CCN(C(=O)C2Cc3ccccc3N2C)CC1

Standard InChI:  InChI=1S/C21H25N3O/c1-16-7-3-5-9-18(16)23-11-13-24(14-12-23)21(25)20-15-17-8-4-6-10-19(17)22(20)2/h3-10,20H,11-15H2,1-2H3

Standard InChI Key:  RDGGXTBAOGMDEE-UHFFFAOYSA-N

Associated Targets(non-human)

Histamine H3 receptor 1015 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 335.45Molecular Weight (Monoisotopic): 335.1998AlogP: 2.70#Rotatable Bonds: 2
Polar Surface Area: 26.79Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.62CX LogP: 3.70CX LogD: 3.70
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.84Np Likeness Score: -1.11

References

1. Huang Z,Yin L,Guan L,Li Z,Tan C.  (2020)  Novel piperazine-2,5-dione analogs bearing 1H-indole: Synthesis and biological effects.,  30  (24): [PMID:33144244] [10.1016/j.bmcl.2020.127654]

Source